National Taiwan University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Real-world dosing of regorafenib in metastatic colorectal cancer (mCRC): Interim analysis from the prospective, observational CORRELATE study

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, pp. iii10